mADRES predicts hepatocellular carcinoma development in patients with hepatitis C virus who achieved sustained virological response.
Toshifumi TadaTakashi KumadaAtsushi HiraokaKazuya KariyamaSatoshi YasudaFujimasa TadaHideko OhamaKazuhiro NousoTomomitsu MatonoShinichiro NakamuraHidenori Toyodanull nullPublished in: Journal of gastroenterology and hepatology (2024)
The mADRES score is useful for predicting HCC development after SVR.